期刊的影响因子--文章列表

期刊文章列表
Manru Huang^1,2，Caiyan Liu^1,2，Yingying Shao^1,2，Shiyue Zhou^1,2，Gaoyong Hu^1,2，Shuangshuang Yin^1,2，Weiling Pu^1,2，Haiyang Yu^1,2（Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae；State Key Laboratory of Component-based Chinese Medicine）.Anti-tumor pharmacology of natural products targeting mitosis[J].癌症生物学与医学(英文版),2022,第6期 Li Dong⁷；Hailian Zhang^2,3,4；Huan Zhang³；Yingnan Ye⁷；Yanan Cheng⁷；Lijuan Li³；Lijuan Wei³；Lei Han⁷；Yandong Cao⁶；Shixia Li³；Xishan Hao^7,3；Juntian Liu^2,3；Jinpu Yu⁷（Cancer Molecular Diagnostics Core , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；Department of Oncology, Tianjin Third Central Hospital, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry；Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；Analyses Technology Co.Ltd.；Cancer Molecular Diagnostics Core , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education）.The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families[J].癌症生物学与医学(英文版),2022,第6期 Sung Uk Lee¹，Jinsil Seong²，Tae Hyun Kim¹，Jung Ho Im^2,3，Woo Chul Kim⁴，Kyubo Kim⁵，Hae Jin Park⁶，Tae Gyu Kim⁷，Youngkyong Kim⁸，Bae Kwon Jeong⁹，Jin Hee Kim¹⁰，Byoung Hyuck Kim¹¹，Taek-Keun Nam¹²（Center for Proton Therapy and Center for Liver and Pancreatobiliary Cancer；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology；Department of Radiation Oncology）.Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma：a multiinstitutional analysis（KROG 19-04）[J].癌症生物学与医学(英文版),2022,第6期 Fengqi Yan^1,2，Qinhao Wang¹，Mingyuan Xia²，Yi Ru¹，Wei Hu²，Guang Yan¹，Xin Xiong¹，Mei Zhang¹，Jiancai Wang¹，Qi Li³，Bo Zhang²，He Wang²，Wei Lin³，Guojun Wu，Xia Li¹（State Key Laboratory of Cancer Biology；Department of Urology；Department of Neurosurgery；Urology and Nephrology Hospital）.MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis[J].癌症生物学与医学(英文版),2022,第6期 Yan Qin¹，Haizhu Chen¹，Peng Liu¹，Changgong Zhang¹，Jianliang Yang¹，Lin Gui¹，Xiaohui He¹，Liqiang Zhou¹，Shengyu Zhou¹，Shiyu Jiang¹，Hongxin Jiang²，Yuankai Shi¹（Department of Medical Oncology；Department of Medical Oncology）.Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP[J].癌症生物学与医学(英文版),2022,第6期 Jun Wang^1,2，Hui Xu¹，Shuang Ge¹，Chaoshuai Xue¹，Hailing Li¹，Xiaotong Jing¹，Ke Liang³，Xiaoying Zhang¹，Cuijuan Zhang^1,3（International License institute of Pathology and Pathophysiology；Department of Pathology；Department of Pathology）.EHMT2（G9a） activation in mantle cell lymphoma and its associated DNA methylation and gene expression[J].癌症生物学与医学(英文版),2022,第6期 Jia Lu^1,2,3；Ting Li^1,3；Zhichao Liao^1,3；Hui Yu⁴；Yongtian Zhao⁴；Haixiao Wu¹；Zhiwu Ren¹；Jun Zhao¹；Ruwei Xing¹；Sheng Teng¹；Yun Yang¹；Xiangchun Li^3,6；Kexin Chen^3,6；Jonathan Trent⁷；Jilong Yang^8,3（Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin's Clinical Research Center for Cancer；Department of Infection Management, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin's Clinical Research Center for Cancer；Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin's Clinical Research Center for Cancer；Yuce Bio Technology Co., Ltd.；Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin’s Clinical Research Center for Cancer；Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer；Sarcoma Multidisciplinary Program, Sylvester Comprehensive Cancer Center, The University of Miami；Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin's Clinical Research Center for CancerTianjin 300060, China）.The efficacies and biomarker investigations of anti-programmed death-1（anti-PD-1）-based therapies for metastatic bone and soft tissue sarcoma[J].癌症生物学与医学(英文版),2022,第6期 Caichen Li^1,2，Huiting Wang^1,2，Yu Jiang²，Wenhai Fu¹，Xiwen Liu²，Ran Zhong^1,2，Bo Cheng²，Feng Zhu³，Yang Xiang¹，Jianxing He^2,4，Wenhua Liang^1,2,5（Department of Thoracic Oncology and Surgery；Dongguan Affiliated Hospital of Southern Medical University；Department of Internal Medicine；Department of Thoracic Surgery；Department of Oncology）.Advances in lung cancer screening and early detection[J].癌症生物学与医学(英文版),2022,第5期 Jianfei Yao^1,2，Yunhuan Zhen³，Jing Fan⁴，Yuan Gong⁵，Yumeng Ye⁶，Shaohua Guo⁷，Hongyi Liu⁷，Xiaoyun Li³，Guosheng Li³，Pan Yang²，Xiaohui Wang²，Danni Liu²，Tanxiao Huang²，Huiya Cao²，Peisu Suo²，Yuemin Li¹，Jingbo Yu⁸，Lele Song^1,2,9（Department of Radiotherapy；HaploX Biotechnology；Department of Colorectal Surgery；International Business School；Department of Gastroenterology；Department of Experimental Pathology；Department of General Surgery；Department of Hepatobiliary Surgery；Comprehensive Liver Cancer Department）.Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population[J].癌症生物学与医学(英文版),2022,第5期 Qiang Zhang¹，Sheng Zhang²，Jianxin Li³，Yi Pan⁴，Jing Zhao²，Yixing Feng²，Yanhui Zhao⁵，Xiaoqing Wang²，Zhiming Zheng⁶，Xiangming Yang⁷，Lixia Liu⁸，Chunxin Qin⁹，Ke Zhao¹⁰，Xiaonan Liu¹¹，Caixia Li¹¹，Liuyang Zhang¹²，Chunrui Yang¹³，Na Zhuo¹⁴，Hong Zhang¹⁵，Jie Liu¹⁶，Jinglei Gao，Xiaoling Di，Fanbo Meng¹⁸，Wei Ji¹⁹，Meng Yang¹⁹，Xiaojie Xin²，Xi Wei²，Rui Jin¹，Lun Zhang¹，Xudong Wang¹，Fengju Song²⁰，Xiangqian Zheng²¹，Ming Gao²¹，Kexin Chen²⁰，Xiangchun Li¹⁹（Department of Maxillofacial and Otorhinolaryngology Oncology；Department of Diagnostic and Therapeutic Ultrasonography；Department of Ultrasonography；Department of Pathology；Department of Ultrasonography；Department of Ultrasonography；Department of Ultrasonography；Department of Ultrasound Room of Functions Branch；Department of Thyroid and Breast Surgery；Department of General Surgery；Department of Thyroid and Breast Surgery；Department of Thyroid Surgery；Department of Pathology；Department of Ultrasonography；Department of Thyroid；Department of Head and Neck Thyroid Surgery；Department of Surgery of Glands；Department of Thyroid and Breast Surgery；Public Laboratory；Department of Epidemiology and Biostatistics；Department of Thyroid and Neck Cancer）.Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports：a retrospective, multi-cohort, diagnostic study[J].癌症生物学与医学(英文版),2022,第5期 Bo Ma^1,2,3，Hanshuang Shao^2,3，Xia Jiang⁴，Zhou Wang^2,5,6,7，Chuanyue (Cary) Wu²，Diana Whaley^2,3，Alan Wells^2,3,7（Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy；Department of Pathology；Pittsburgh VA Healthcare System；Department of Biomedical Informatics；Department of Urology；Department of Pharmacology and Chemical Biology；UPMC Hillman Cancer Center）.Akt isoforms differentially provide for chemoresistance in prostate cancer[J].癌症生物学与医学(英文版),2022,第5期 Fan Kou¹，Lei Wu¹，Yan Guo¹，Bailu Zhang¹，Baihui Li¹，Ziqi Huang¹，Xiubao Ren^1,2，Lili Yang¹（Department of Immunology；Department of Biotherapy）.Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy[J].癌症生物学与医学(英文版),2022,第5期 Panpan Ma^1,2,3，Xinxin Jin¹，Zhiwei Fan¹，Zhou Wang⁴，Suhui Yue¹，Changyue Wu⁵，Shiyin Chen¹，Yuanyuan Wu¹，Miaomiao Chen¹，Donghua Gu⁶，Siliang Zhang⁷，Renfang Mao⁸，Yihui Fan^1,2（Laboratory of Medical Science；Department of Pathogenic Biology；Department of Clinical Laboratory；School of Life Sciences；Department of Dermatology；The Department of Urology；The Department of Radiotherapy Oncology；Department of Pathophysiology）.Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling[J].癌症生物学与医学(英文版),2022,第5期 Zilu Zhang¹，Chenjing Ye²，Jia Liu¹，Wenbin Xu²，Chao Wu²，Qing Yu²，Xiaoguang Xu¹，Xinyi Zeng¹，Huizi Jin³，Yingli Wu⁴，Hua Yan^1,2（Shanghai Institute of Hematology，Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine；VIP Health Center，Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine；Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs，School of Pharmacy，Shanghai Jiao Tong University；Hongqiao International Institute of Medicine，Shanghai Tongren Hospital/Faculty of Basic Medicine，Chemical Biology Division of Shanghai Universities E-Institutes，Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education，Shanghai Jiao Tong University School of Medicine）.JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKK[J].Cancer Biology & Medicine,2022,第5期 Litong Yao¹，Zhiyuan Pang²，Mozhi Wang¹，Mengshen Wang¹，Xiangyu Sun¹，Mingke Cui²，Yanfu Zheng²，Xinyan Li¹，Haoran Dong¹，Qiang Zhang²，Yingying Xu¹（Department of Breast Surgery；Department of Breast Surgery）.The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice：results from a population-based, real world study[J].癌症生物学与医学(英文版),2022,第5期 Wen Liu¹，Xuejing Yan²，Ruochuan Cheng¹（Department of Thyroid Surgery；Department of Management of Chronic Non-communicable Diseases）.The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas：is China ready?[J].癌症生物学与医学(英文版),2022,第5期 Yali Chen，Cuihong Yang，Ning Li，Zixing Wang，Peng Wu，Jin Du，Jingmei Jiang（Department of Epidemiology and Biostatistics）.Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004–2017：a population-based study[J].癌症生物学与医学(英文版),2022,第5期 Wenqi Du^1,2，Ruicheng Zhang³，Bilal Muhammad³，Dongsheng Pei¹（Department of Pathology；Department of Human Anatomy；Department of Neurology）.Targeting the COP9 signalosome for cancer therapy[J].癌症生物学与医学(英文版),2022,第5期 Jiakang Li^1,2，Jingyan Xu^2,3，Mingyi Yang^1,2，Qing Zhou²（School of Medicine, South China University of Technology；Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences；The Second School of Clinical Medicine, Southern Medical University；Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences）.Therapeutic revolution for inoperable stage Ⅲ non-small cell lung cancer in the immune era[J].癌症生物学与医学(英文版),2022,第5期 Han Liang（Gastric Cancer Center）.PD-1 inhibitors provide new opportunities in conversion therapy for stage Ⅳ gastric cancer[J].癌症生物学与医学(英文版),2022,第5期 Vladimir Semiglazov，Andrey Tseluiko，Asel Kudaybergenova，Anna Artemyeva，Petr Krivorotko，Roman Donskih（Petrov National Medicine Cancer-Research Center Ministry of Health）.Immunology and immunotherapy in breast cancer[J].癌症生物学与医学(英文版),2022,第5期 Junjie Li^1,2，Li Chen^1,2，Wei Tan³，Fang Qi⁴，Yang Zhang⁴，Zhonghua Wang^1,2，Zhimin Shao^1,2（Key Laboratory of Breast Cancer in Shanghai；Department of Oncology；Nottingham Clinical Trials Unit；Academic Department）.Platinum is essential in neoadjuvant treatment of triple-negative breast cancer：a network meta-analysis[J].癌症生物学与医学(英文版),2022,第5期 Rui Ding^1,2，Yi Xiao^1,2，Miao Mo³，Ying Zheng³，Yi-Zhou Jiang^1,2，Zhi-Ming Shao^1,2,4（Key Laboratory of Breast Cancer in Shanghai；Department of Oncology；Department of Cancer Prevention；Precision Cancer Medicine Center）.Breast cancer screening and early diagnosis in Chinese women[J].癌症生物学与医学(英文版),2022,第4期 Hui Lu^1,2,3,4；Shanshan Guo^1,2,3,5；Liting Liu^1,2,3,5；Qiuyan Chen^1,2,3,5；Yujing Liang^1,2,3,5；Sailan Liu^1,2,3,5；Xuesong Sun^1,2,3,5；Qingnan Tang^1,2,3,5；Xiaoyun Li^1,2,3,5；Ling Guo^1,2,3,5；Haoyuan Mo^1,2,3,5；Linquan Tang^1,2,3,5；Haiqiang Mai^1,2,3,5（State Key Laboratory of Oncology in South China；Collaborative Innovation Center for Cancer Medicine；Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center；Department of Radiation Oncology,Guangzhou Concord Cancer Center；Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center）.Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma：a long-term follow-up study[J].癌症生物学与医学(英文版),2022,第4期 Siyi Zheng¹，Hui Han¹，Shuibin Lin²（Center for Translational Medicine；Department of Otolaryngology）.N~6-methyladenosine（m~6A） RNA modification in tumor immunity[J].癌症生物学与医学(英文版),2022,第4期 Shuo Wang¹，Yuantong Liu¹，Lu Zhang¹，Zhijun Sun^1,2（The State Key Laboratory Breeding Base of Basic Science of Stomatology（Hubei-MOST）&Key Laboratory of Oral Biomedicine；Department of Oral Maxillofacial-Head Neck Oncology）.Methods for monitoring cancer cell pyroptosis[J].癌症生物学与医学(英文版),2022,第4期 Wei Tang¹，Yu Wu¹，Xin Qi¹，Rilei Yu¹，Zhimin Lu²，Ao Chen¹，Xinglong Fan³，Jing Li^1,4,5（Key Laboratory of Marine Drugs；Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease of the First Affiliated Hospital；Department of Thoracic Surgery；Open Studio for Druggability Research of Marine Natural Products；Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology）.PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells[J].癌症生物学与医学(英文版),2022,第4期 Qian Geng^1,2，Ruiting Xian¹，Yinjue Yu¹，Fengsheng Chen³，Rong Li¹（Department of Oncology；Cancer Center；Integrated Hospital of Traditional Chinese Medicine）.SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer[J].癌症生物学与医学(英文版),2022,第4期 Yu Deng，Hongyan Jin（Department of Obstetrics and Gynecology）.Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells[J].癌症生物学与医学(英文版),2022,第4期 Jingrong Xian^1,2,3,4，Shiwen Wang^1,2,3,4，Yanyu Jiang²，Lihui Li²，Lili Cai²，Ping Chen⁵，Yue Liu^1,2,3,4，Xiaofei Zeng⁶，Guoan Chen⁶，Chen Ding^7,8，Robert M. Hoffman^9,10，Lijun Jia²，Hu Zhao^1,3,4，Yanmei Zhang^1,3,4（Department of Laboratory Medicine；Cancer Institute；Research Center on Aging and Medicine；Shanghai Key Laboratory of Clinical Geriatric Medicine；Department of Basic Science of Oncology；School of Medicine；State Key Laboratory of Genetic Engineering；State Key Laboratory of Cell Differentiation and Regulation；Department of Surgery；Anticancer Inc.）.Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma[J].癌症生物学与医学(英文版),2022,第4期首页上一页 1 2 3 4 5 下一页尾页共有5页，转到页

期刊文章列表